Related Experiment Videos

Artificial intelligence in cardiology: implications for healthcare outcomes

Mikayla N Harris1, Parth Desai1, Eric Yalley1

  • 1Department of Physiology and Biophysics, College of Medicine, Howard University, Washington, DC, United States.

Insights

Artificial Intelligence (AI) in cardiology must address care variabilities affecting diverse populations. Future AI models require inclusive data and equitable research to ensure accuracy and fairness for all patients.

Area of Science:

  • Cardiology
  • Medical Informatics
  • Health Equity

Background:

  • Cardiovascular medicine faces significant diagnostic and treatment variabilities impacting diverse racial, ethnic, and gender groups.
  • Current Artificial Intelligence (AI) and precision medicine efforts in cardiology often overlook these disparities, risking the perpetuation of historical inequities.
  • AI models trained on non-representative data may embed biases into clinical decision-support systems, exacerbating existing healthcare gaps.

Purpose of the Study:

  • To review existing variabilities in cardiovascular disease (CVD) care delivery across different age groups and demographic populations.
  • To examine factors contributing to adverse healthcare outcomes, including genetic predispositions, access to care, health literacy, insurance coverage, and treatment adherence.
  • To highlight the disproportionate impact of CVD on specific populations, such as Black patients with heart failure and hypertension, and minority children with CVD.

Main Methods:

  • An integrative review approach was employed to analyze current variabilities in cardiovascular care.
  • Examination of factors contributing to healthcare disparities, including genetic, socioeconomic, and systemic issues.
  • Analysis of the implications of non-representative data in the development of AI and precision medicine tools for cardiology.

Main Results:

  • Significant variabilities in cardiovascular care persist, disproportionately affecting younger (<65 years) and older (≥65 years) adults, as well as racial and ethnic minorities.
  • Black patients exhibit higher rates of heart failure and hypertension, with Black women facing particular challenges due to multifaceted factors.
  • Racially and ethnically diverse children with CVD have a higher mortality risk compared to their White counterparts.

Conclusions:

  • The integration of AI in cardiovascular medicine necessitates a foundational restructuring of systems to mitigate outcome variabilities.
  • Future research must prioritize diverse genomic datasets and equitable representation in clinical trials to ensure fairness.
  • Collaboration with institutions serving diverse communities is crucial for developing equitable and accurate AI and precision medicine models in cardiology.

Related Concept Videos

Issues And Trends In Healthcare Delivery System01:29

Issues And Trends In Healthcare Delivery System

The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...